This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sunesis Pharmaceuticals, Inc.. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: The Innovative Contributions of Tamilarasan Subramani
Introduction
Tamilarasan Subramani is a notable inventor based in Karur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of complex chemical compounds. With a total of 3 patents to his name, his work has the potential to impact various therapeutic applications.
Latest Patents
Subramani's latest patents focus on the method of preparing a specific compound, namely (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid. These patents disclose methods for preparing this compound and also provide pharmaceutical compositions that include it. Furthermore, the patents outline methods of treatment utilizing these compositions, showcasing the practical applications of his research.
Career Highlights
Tamilarasan Subramani is currently associated with Sunesis Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to advancing drug development and improving treatment options for patients.
Collaborations
Throughout his career, Subramani has collaborated with notable colleagues, including Anantha R Sudhakar and Ramar Subbiah. These collaborations have likely enriched his research and expanded the scope of his inventions.
Conclusion
Tamilarasan Subramani's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to advancing medical science. His work not only highlights his expertise but also the potential for significant advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
